Home » Loper Bright no free pass where FDA’s LDT rule is concerned

To read the full story, subscribe or sign in.

Loper Bright no free pass where FDA’s LDT rule is concerned

Feb. 26, 2025

By Mark McCarty

The FDA’s final rule for lab-developed tests (LDTs) is in litigation, and a district court decision may be shortly in the works.

BioWorld MedTech Regulatory Diagnostics U.S. FDA